Earnings summaries and quarterly performance for HEALTHCARE SERVICES GROUP.
Executive leadership at HEALTHCARE SERVICES GROUP.
Theodore Wahl
Detailed
President & Chief Executive Officer
CEO
AM
Andrew M. Brophy
Detailed
Senior Vice President, Controller & Chief Accounting Officer
AW
Andrew W. Kush
Detailed
Executive Vice President & Chief Operating Officer
JB
Jason Bundick
Detailed
Executive Vice President, Chief Compliance Officer, General Counsel & Secretary
JC
John C. Shea
Detailed
Executive Vice President & Chief Administrative Officer
PJ
Patrick J. Orr
Detailed
Executive Vice President & Chief Revenue Officer
VS
Vikas Singh
Detailed
Executive Vice President & Chief Financial Officer
Board of directors at HEALTHCARE SERVICES GROUP.
Research analysts who have asked questions during HEALTHCARE SERVICES GROUP earnings calls.
AJ
Andrew J. Wittmann
Robert W. Baird & Co.
5 questions for HCSG
Also covers: ABM, ACM, APG +17 more
Matthew Mardula
William Blair
5 questions for HCSG
Also covers: ASTH, LFST, MD +2 more
Sean Dodge
RBC Capital Markets
4 questions for HCSG
Also covers: CDMO, CTLT, EVH +13 more
AR
A.J. Rice
UBS Group AG
3 questions for HCSG
Also covers: ACHC, AMED, AMN +21 more
AR
Albert Rice
UBS
3 questions for HCSG
Also covers: ACHC, AMED, AMN +21 more
Tao Qiu
Macquarie Group
3 questions for HCSG
Also covers: ADUS, AMED, BKD +5 more
BS
Bill Sutherland
The Benchmark Company LLC
2 questions for HCSG
Also covers: AMED, ATIP, BEAT +9 more
JS
Jack Senft
William Blair
2 questions for HCSG
Also covers: AMWL, LFST, MD +3 more
AR
A.J. Rice
UBS
1 question for HCSG
Also covers: ACHC, ADUS, AMN +14 more
AJ
Albert J. William Rice
UBS Investment Bank
1 question for HCSG
James
Jefferies
1 question for HCSG
Also covers: BMI, CAH, EHC +5 more
RD
Ryan Daniels
William Blair & Company, L.L.C.
1 question for HCSG
Also covers: ACCD, AGL, ALHC +12 more
WS
William Sutherland
The Benchmark Company
1 question for HCSG
Also covers: AMN, AONC, BEAT +10 more
Recent press releases and 8-K filings for HCSG.
Healthcare Services Group Reports Strong Q4 2025 Results and Announces New Share Repurchase Plan
HCSG
Earnings
Guidance Update
Share Buyback
- Healthcare Services Group reported Q4 2025 revenue of $466.7 million, a 6.6% increase over the prior year, with net income of $31.2 million and diluted earnings per share of $0.44.
- For the full year 2025, revenue increased over 7%, and the campus division reached over $100 million in revenue. The company concluded 2025 with $203.9 million in cash and marketable securities.
- The company projects mid-single-digit revenue growth for full year 2026, with Q1 2026 revenue estimated between $460-$465 million.
- HCSG announced a new $75 million share repurchase plan for the next 12 months, having completed its previous $50 million plan five months ahead of schedule.
- Strategic priorities for 2026 include driving growth, managing costs (targeting 86% for cost of services and 9.5%-10.5% for SG&A), and optimizing cash flow, supported by favorable demographic trends and enhanced contracts.
Feb 11, 2026, 1:30 PM
HCSG Reports Strong Q4 2025 Results and Announces New $75 Million Share Repurchase Plan
HCSG
Earnings
Guidance Update
Share Buyback
- Healthcare Services Group (HCSG) reported Q4 2025 revenue of $466.7 million, a 6.6% increase over the prior year, and diluted earnings per share of $0.44.
- For the full year 2025, HCSG exceeded initial expectations with over 7% year-over-year revenue growth and returned over $60 million of capital through its share repurchase program.
- The company expects mid-single-digit revenue growth for the full year 2026, with Q1 2026 revenue projected in the $460-$465 million range. HCSG aims to manage cost of services in the 86% range and SG&A in the 9.5%-10.5% range for 2026.
- HCSG completed its $50 million share repurchase plan five months early and announced a new plan to repurchase $75 million of common stock over the next 12 months.
- The company ended 2025 with a strong liquidity position, including $203.9 million in cash and marketable securities and an undrawn $300 million credit facility, enabling it to pursue organic growth, M&A, and share buybacks.
Feb 11, 2026, 1:30 PM
Healthcare Services Group Reports Strong Q4 2025 Results and Announces New Share Repurchase Plan
HCSG
Earnings
Guidance Update
Share Buyback
- Healthcare Services Group (HCSG) reported Q4 2025 revenue of $466.7 million, a 6.6% increase over the prior year, and diluted earnings per share of $0.44. The campus division achieved over $100 million in revenue for 2025.
- For 2026, HCSG projects mid-single-digit revenue growth for the full year, with Q1 revenue expected in the $460-$465 million range. The company aims to manage cost of services in the 86% range and SG&A between 9.5%-10.5%.
- The company completed its $50 million share repurchase plan five months ahead of schedule and announced a new plan to repurchase $75 million of common stock over the next 12 months.
- HCSG concluded 2025 with a robust liquidity position, holding $203.9 million in cash and marketable securities and an undrawn $300 million revolving credit facility.
Feb 11, 2026, 1:30 PM
Healthcare Services Group Reports Strong Q4 and Full-Year 2025 Results, Announces New Share Repurchase Program
HCSG
Earnings
Guidance Update
Share Buyback
- For Q4 2025, revenue was $466.7 million, a 6.6% increase over the prior year, contributing to full-year 2025 revenue of $1.84 billion, up 7.1%.
- Q4 2025 saw net income of $31.2 million and diluted EPS of $0.44. For the full year 2025, net income was $59.1 million and diluted EPS was $0.81.
- The company completed its $50.0 million share repurchase plan and authorized a new $75.0 million, 12-month share repurchase program.
- Healthcare Services Group exceeded its 2025 expectations and anticipates mid-single-digit revenue growth for 2026.
Feb 11, 2026, 12:01 PM
HCSG Reports Full Year and Fourth Quarter 2025 Results and New Share Repurchase Program
HCSG
Earnings
Guidance Update
Share Buyback
- Healthcare Services Group (HCSG) reported full-year 2025 revenue of $1.84 billion and diluted EPS of $0.81, exceeding initial expectations. For the fourth quarter of 2025, revenue was $466.7 million and diluted EPS was $0.44.
- The company anticipates mid-single-digit revenue growth for 2026 , with goals to manage cost of services in the 86% range and SG&A between 9.5% and 10.5%.
- HCSG completed its $50.0 million share repurchase program and authorized a new $75.0 million, 12-month program. The company ended the year with $203.9 million in cash and marketable securities and an unutilized $300.0 million credit facility.
Feb 11, 2026, 12:00 PM
HCSG: MEDVi GLP-1 Telehealth Platform Analysis
HCSG
New Projects/Investments
- MEDVi operates as a telehealth platform that connects consumers with licensed prescribers for compounded GLP-1 medications, which are explicitly stated as not FDA-approved or evaluated for safety, efficacy, or quality as finished products.
- The platform functions on a cash-pay service model, with affiliated medical providers operating outside of health insurance networks, potentially appealing to consumers without GLP-1 insurance coverage.
- MEDVi reports an average weight loss of 18 percent and that 93 percent of participants kept the weight off, based on self-reported patient data; however, the company emphasizes that results vary widely and are not representative of typical outcomes.
- The telehealth weight loss and compounded medication sectors are currently facing increased regulatory scrutiny.
Jan 10, 2026, 3:28 AM
HCSG Reports Strong Q3 2025 Results with Increased Revenue and EPS, Provides Q4 Outlook
HCSG
Earnings
Guidance Update
Share Buyback
- HCSG reported Q3 2025 revenue of $464.3 million, an 8.5% increase over the prior year, with net income of $43 million and diluted earnings per share of $0.59.
- The company estimates Q4 revenue to be in the range of $460 million to $470 million and expects to manage SG&A in the 9.5% to 10.5% range in the near term.
- Cash flow from operations was $71.3 million, including a $31.8 million benefit related to ERC receipts, contributing to a strong balance sheet with $207.5 million in cash and marketable securities at quarter-end.
- HCSG repurchased $27.3 million of common stock in Q3, bringing year-to-date buybacks to $42 million under a $50 million share repurchase plan valid through June 2026.
- Strategic priorities for Q4 include driving growth, managing costs, and optimizing cash flow, while the company continues to service Genesis facilities without operational disruption during their bankruptcy process.
Oct 22, 2025, 12:30 PM
HCSG Reports Strong Q3 2025 Revenue Growth and Positive Earnings Impact from ERC
HCSG
Earnings
Guidance Update
Share Buyback
M&A
- Healthcare Services Group (HCSG) reported Q3 2025 revenue of $464.3 million, an 8.5% increase year-over-year, and anticipates Q4 2025 revenue between $460 million and $470 million.
- Diluted earnings per share were $43.59 in Q3 2025, benefiting from a $0.36 per share impact primarily related to the Employee Retention Credit (ERC).
- The company maintained a strong balance sheet with $207.5 million in cash and marketable securities at quarter-end and executed $27.3 million in common stock repurchases during Q3, totaling $42 million year-to-date.
- Strategic priorities for Q4 2025 focus on driving growth through new client wins and retention, cost management, and cash flow optimization, with the "campus initiative" identified as the primary target for future acquisitions.
- HCSG noted a strong labor market with stabilized wage growth and record application levels, and confirmed continued service provision to Genesis Healthcare facilities amidst their bankruptcy process.
Oct 22, 2025, 12:30 PM
Healthcare Services Group, Inc. Reports Strong Q3 2025 Results
HCSG
Earnings
Revenue Acceleration/Inflection
Share Buyback
- Healthcare Services Group, Inc. reported revenue of $464.3 million for the three months ended September 30, 2025, marking an 8.5% increase over the prior year.
- Net income was $43.0 million and diluted EPS was $0.59 for Q3 2025, which included a $0.361 benefit primarily related to the Employee Retention Credit (ERC).
- Cash flow from operations totaled $71.3 million, or $87.1 million excluding the change in payroll accrual, with a $31.8 million benefit related to the ERC.
- The company maintained strong liquidity with $207.5 million in cash and marketable securities as of September 30, 2025, and repurchased $27.3 million of common stock during the quarter.
Oct 22, 2025, 11:02 AM
HCSG Reports Third Quarter 2025 Results
HCSG
Earnings
Share Buyback
Revenue Acceleration/Inflection
- Healthcare Services Group (HCSG) reported third quarter 2025 revenue of $464.3 million, an 8.5% increase over the prior year, with net income of $43.0 million and diluted EPS of $0.59.
- The diluted EPS includes a $0.361 benefit primarily related to the Employee Retention Credit (ERC), which also contributed a $31.8 million benefit to cash flow from operations.
- Cash flow from operations for the quarter was $71.3 million, or $87.1 million excluding the change in payroll accrual.
- The company repurchased $27.3 million of its common stock during the third quarter under its $50.0 million share repurchase plan.
- As of September 30, 2025, HCSG had cash and marketable securities totaling $207.5 million.
Oct 22, 2025, 11:00 AM
Quarterly earnings call transcripts for HEALTHCARE SERVICES GROUP.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more